Related Experiment Video
Updated: Nov 15, 2025
07:41
Insertion, Maintenance, and Removal of the Percutaneous Dual Lumen Cannula Right Ventricular Assist Device
Published on: July 20, 2022
2.1K
Right heart failure considerations in pediatric ventricular assist devices
Sabrina P Law1, David L S Morales2, Ming-Sing Si3
1Morgan Stanley Children's Hospital of New York, New York, NY, USA.
Pediatric Transplantation
|March 5, 2021
Summary
Right heart failure after pediatric left ventricular assist device (LVAD) implantation is a significant challenge. This review shares best practices to improve outcomes for children with LVADs.
Area of Science:
- Pediatric cardiology
- Mechanical circulatory support
- Pediatric cardiac surgery
Background:
- Right heart failure (RHF) complicates pediatric left ventricular assist device (LVAD) implantation.
- RHF adversely affects transplant eligibility and survival in pediatric patients.
- Limited pediatric-specific evidence exists to guide RHF management post-LVAD.
Purpose of the Study:
- To review the current literature on pediatric RHF after LVAD.
- To describe a harmonized approach to RHF management from the ACTION network.
- To enhance RHF outcomes by sharing best practices in the pediatric VAD community.
Main Methods:
- Comprehensive literature review focused on pediatric RHF and LVADs.
- Synthesis of existing evidence and clinical experience.
- Description of a consensus-based management strategy.
Main Results:
- Identified key challenges and risk factors for RHF in pediatric LVAD patients.
- Outlined a structured approach for anticipation, prevention, and early identification of RHF.
- Provided guidance on medical and device management strategies for RHF.
Conclusions:
- Effective management of RHF is crucial for successful pediatric LVAD outcomes.
- A harmonized, evidence-informed approach can improve RHF care.
- Sharing best practices across the pediatric VAD community is essential for advancing patient care.
Related Concept Videos
01:22Heart Failure VI: Adjunct Therapies
101
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
101
01:29Cardiomyopathy V: Interprofessional Care
119
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
119
01:30Cardiomyopathy II: Dilated Cardiomyopathy
146
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
146
01:30Heart Failure V: Medical Management
85
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
85
01:29Cardiomyopathy III: Hypertrophic Cardiomyopathy
144
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
144
01:29Heart Failure II: Pathophysiology
200
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
200